Boston Trust Walden Corp Trims Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Boston Trust Walden Corp lessened its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 2.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 518,675 shares of the company’s stock after selling 13,138 shares during the quarter. Boston Trust Walden Corp owned 3.43% of U.S. Physical Therapy worth $46,012,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. State Street Corp grew its position in U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after purchasing an additional 99,244 shares during the period. Copeland Capital Management LLC boosted its stake in shares of U.S. Physical Therapy by 9.5% in the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock worth $74,459,000 after buying an additional 72,715 shares during the last quarter. Southernsun Asset Management LLC grew its holdings in U.S. Physical Therapy by 10.5% during the third quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock worth $46,302,000 after acquiring an additional 52,062 shares during the period. Penn Davis Mcfarland Inc. purchased a new position in U.S. Physical Therapy during the third quarter valued at approximately $2,552,000. Finally, Rockefeller Capital Management L.P. lifted its holdings in U.S. Physical Therapy by 18.8% in the third quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock valued at $13,578,000 after acquiring an additional 25,393 shares during the period.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, insider Eric Joseph Williams sold 2,000 shares of the business’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $95.84, for a total transaction of $191,680.00. Following the transaction, the insider now owns 14,814 shares of the company’s stock, valued at approximately $1,419,773.76. The trade was a 11.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Carey P. Hendrickson sold 516 shares of the company’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the completion of the sale, the chief financial officer now owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 7,412 shares of company stock worth $706,605. Corporate insiders own 1.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on USPH shares. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $100.00 to $115.00 in a research note on Monday, December 16th. Barrington Research reissued an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 21st. JPMorgan Chase & Co. lifted their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Tuesday, December 3rd. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They set an “outperform” rating and a $113.00 target price on the stock. Finally, Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, U.S. Physical Therapy has an average rating of “Buy” and an average target price of $114.00.

U.S. Physical Therapy Stock Down 0.6 %

USPH opened at $88.22 on Tuesday. The company has a market cap of $1.33 billion, a PE ratio of 93.85, a price-to-earnings-growth ratio of 3.65 and a beta of 1.48. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63. The company has a 50-day moving average price of $91.85 and a 200 day moving average price of $88.56. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.